Prodesse

About:

Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications.

Top Investors: Wisconsin Investment Partners, Silicon Pastures, Jeff Rusinow, Andrew Shannon, Thomas Shannon

Description:

Prodesse develops molecular diagnostic reagents for a variety of infectious disease applications. Prodesse sells three FDA 510(k) cleared products in the United States, and two additional CE-marked products in Europe. The company's products can be used in conjunction with various nucleic acid extraction and real-time PCR (polymerase chain reaction) platforms, including Cepheid's SmartCycler(Â®) II System.

Total Funding Amount:

$1.5M

Headquarters Location:

Milwaukee, Wisconsin, United States

Founded Date:

1993-01-01

Founders:

Kelly Henrickson, Thomas Shannon

Number of Employees:

1-10

Last Funding Date:

2002-01-01

IPO Status:

Private

Industries: